SPEAR T-CELL Trademark

Trademark Overview


On Monday, August 15, 2016, a trademark application was filed for SPEAR T-CELL with the United States Patent and Trademark Office. The USPTO has given the SPEAR T-CELL trademark a serial number of 79196925. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, February 26, 2024. This trademark is owned by Adaptimmune Limited. The SPEAR T-CELL trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical treatment services, namely, administration of gene therapy to patients involving harvesting a patient's white blood cells, transducing or combining white blood cells with gene encoding T-cell receptor and re-administration of white blood cells to patient; Medical and therapeutic services, namely immunotherapy services comprising harvesting a patient's white blood cells, transducing the white blood cells with the gene encoding the engineered T-cell receptor and re-administration of the transduced white blood cells back into the patient

Pharmaceutical preparations for the treatment of cancer and autoimmune diseases; immunotherapy preparations for the treatment of cancer and autoimmune diseases; T-cell receptors; immunotherapy preparations comprising engineered T-cell receptors; immunotherapy preparations comprising genes encoding engineered T-cell receptors
spear t-cell

General Information


Serial Number79196925
Word MarkSPEAR T-CELL
Filing DateMonday, August 15, 2016
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, February 26, 2024
Registration Number5248245
Registration DateTuesday, July 25, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 9, 2017

Trademark Statements


Goods and ServicesMedical treatment services, namely, administration of gene therapy to patients involving harvesting a patient's white blood cells, transducing or combining white blood cells with gene encoding T-cell receptor and re-administration of white blood cells to patient; Medical and therapeutic services, namely immunotherapy services comprising harvesting a patient's white blood cells, transducing the white blood cells with the gene encoding the engineered T-cell receptor and re-administration of the transduced white blood cells back into the patient
Goods and ServicesPharmaceutical preparations for the treatment of cancer and autoimmune diseases; immunotherapy preparations for the treatment of cancer and autoimmune diseases; T-cell receptors; immunotherapy preparations comprising engineered T-cell receptors; immunotherapy preparations comprising genes encoding engineered T-cell receptors
NOT AVAILABLE"T-CELL"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 1, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 1, 2016
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAdaptimmune Limited
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressAbingdon Oxfordshire OX14 4RX
GB

Party NameAdaptimmune Limited
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressGB

Party NameAdaptimmune Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressGB

Trademark Events


Event DateEvent Description
Thursday, November 24, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, December 1, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 1, 2016ASSIGNED TO EXAMINER
Friday, December 2, 2016NON-FINAL ACTION WRITTEN
Saturday, December 3, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, December 6, 2016APPLICATION FILING RECEIPT MAILED
Tuesday, December 6, 2016REFUSAL PROCESSED BY MPU
Tuesday, December 6, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, December 24, 2016REFUSAL PROCESSED BY IB
Tuesday, March 28, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 28, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 28, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 29, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 28, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 19, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 9, 2017PUBLISHED FOR OPPOSITION
Tuesday, May 9, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 25, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, October 25, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, November 2, 2017FINAL DISPOSITION PROCESSED
Thursday, November 2, 2017FINAL DISPOSITION NOTICE SENT TO IB
Thursday, November 2, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, November 24, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 26, 2019NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 25, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, June 13, 2023TEAS SECTION 71 & 15 RECEIVED
Wednesday, February 21, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, February 26, 2024REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Monday, February 26, 2024NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Saturday, November 22, 2025NEW REPRESENTATIVE AT IB RECEIVED